Nuanced Belatacept Dosing

Speaker: Erika Meredith, PharmD, BCTXP
Clinical Pharmacy Specialist, Kidney/Pancreas Transplant
Emory University Hospital

A Knowledge-Based Activity

ACPE UAN: 0016-9999-24-068-L01-P, 0.75 contact hours (0.075 CEUs)
CNE Credit: 0.75 hours CNE

Learning Objectives:

• Review key components of strategies for conversion to belatacept that are safe and effective
• Choose an appropriate candidate for alternative belatacept dosing, and design a safe alternative dosing
  regimen
• Examine belatacept regimens which reduce immunosuppression and mitigate infection

Disclosures:

Dr. Erika Meredith has no relevant financial conflicts of interest to disclose in relation to this activity.